Contents

Volume 2, Issue 5 MAY 2020

COLUMNS
PROTEOMICS, DIGESTIVE DISEASES & METABOLISM …….….……….……………………..5
Can Intermittent Fasting Protect against Cancer, Metabolic Syndrome, Cognitive and
Neuropsychiatric Diseases?
https://doi.org/10.37756/bk.20.2.5.1
PROTEIN ENGINEERING ………………….………………….……………………..…..…………..11
Designer Proteins for New Vaccines and Therapeutics
https://doi.org/10.37756/bk.20.2.5.2
REVIEW ARTICLES
AGING ………………………..……………………………………………………..………..….…….18
Worries make you look older: unraveling the science that connects stress with graying in
human beings
https://doi.org/10.37756/bk.20.2.5.3
MYOCARDIAL COMPLICATIONS AND COVID-19 INFECTIONS ………………….………….24
Impact of COVID-19 on cardiovascular patients
https://doi.org/10.37756/bk.20.2.5.4

BIOTECH R&D AND INNOVATION NEWS…………………………………….……………….…33
Editor’s PICKS: Biotechnology Advances around the World
Cancer Biology ………………………………..…………………………………….………………..35
Microorganisms and Bacteria …………………….…..…..………………….……….……………35
Regenerative Medicine………………………….…………………….…….……….………………36
Plant and Agriculture Biotechnology…………………………………………………………….37

BIOTECH AND PHARMA INDUSTRY ROUNDUP..……………………………………….……..38
Eli Lilly’s Tauvid imaging agent approved by FDA to diagnose AD …..…………..……….38
ZILXI™ (minocycline), receives FDA approval for rosacea in adults………….………..….38
Eagle Pharma to test Ryanodex against COVID-19…………………………………………….38
Meningococcal Vaccines expected to touch USD 9 billion by 2026 ………………………..39
Novartis partners with Eye & Ear hospital to manufacture coronavirus vaccine…………39
AstraZeneca to study leukemia drug as COVID-19 treatment………………………..………39
Large scale phase 2 & 3 trials are underway for coronavirus vaccine……………………..39
Investments to counter Cancer genes…………………………………..…………………………40
Roche presents biomarker for cancer.……………………………..……………………..………40
HALIX B.V. to produce vaccines against COVID-19…………………………………………….40
SARS-CoV2 antibody tests might not be suitable for individual diagnosis………………..40